Boston Partners
SRGA

Boston Partners’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Boston Partners’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5,597
Closed -$1.01M – 715
2019
Q1 		$1.01M Sell
5,597
-8,655
-61% -$1.25M ﹤0.01% 622
2018
Q4 		$1.58M Buy
14,252
+4,562
+47% +$594K ﹤0.01% 584
2018
Q3 		$1.31M Buy
+9,690
New +$1.34M ﹤0.01% 656

Other funds holding SRGA

PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HC
Hillman Company Pittsburgh, Pennsylvania $257M AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners's SRGA Position: Q2 2019 in Review

Boston Partners sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2019, closing a stake of 5,597 shares — an estimated $1.01M sold.

Boston Partners first reported a position in SRGA in Q3 2018 and held it in 3 quarters. The position peaked at $1.58M in Q4 2018. 106 funds tracked by Wall St. Rank hold SRGA as of Q2 2019.

  • Boston Partners reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Boston Partners sold 5,597 Surgalign Holdings, Inc. Common Stock shares in Q2 2019, an estimated $1.01M.
  • Boston Partners first reported a position in Surgalign Holdings, Inc. Common Stock in Q3 2018 and held it in 3 quarters.
  • Boston Partners's Surgalign Holdings, Inc. Common Stock position peaked at $1.58M in Q4 2018.
  • 106 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2019.

Based on Boston Partners's 13F filing for Q2 2019, filed 9 Aug 2019.